| Year |
Citation |
Score |
| 2020 |
Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R. COVID-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes. PMID 32938731 DOI: 10.2337/Dbi20-0032 |
0.345 |
|
| 2020 |
Guo K, Eid SA, Elzinga SE, Pacut C, Feldman EL, Hur J. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clinical Epigenetics. 12: 123. PMID 32787975 DOI: 10.1186/S13148-020-00913-6 |
0.333 |
|
| 2020 |
Stino AM, Rumora AE, Kim B, Feldman EL. Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. Journal of the Peripheral Nervous System : Jpns. PMID 32412144 DOI: 10.1111/Jns.12387 |
0.374 |
|
| 2020 |
Christensen DH, Knudsen ST, Gylfadottir SS, Christensen LB, Nielsen JS, Beck-Nielsen H, Sørensen HT, Andersen H, Callaghan BC, Feldman EL, Finnerup NB, Jensen TS, Thomsen RW. Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort. Diabetes Care. PMID 32295810 DOI: 10.2337/Dc19-2277 |
0.354 |
|
| 2020 |
Savelieff MG, Callaghan BC, Feldman EL. The emerging role of dyslipidemia in diabetic microvascular complications. Current Opinion in Endocrinology, Diabetes, and Obesity. 27: 115-123. PMID 32073426 DOI: 10.1097/Med.0000000000000533 |
0.353 |
|
| 2020 |
Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL, Martin CL, White NH, Orchard TJ, Lopes-Virella M, Lachin JM, Pop-Busui R. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. PMID 32051148 DOI: 10.2337/Db19-1046 |
0.344 |
|
| 2020 |
Callaghan BC, Gallagher G, Fridman V, Feldman EL. Diabetic neuropathy: what does the future hold? Diabetologia. PMID 31974731 DOI: 10.1007/S00125-020-05085-9 |
0.357 |
|
| 2020 |
Reynolds EL, Nelson RG, Akinci G, Henn R, Patterson A, Feldman EL, Callaghan BC. 532-P: The Longitudinal Determinants of Diabetic Complications in the Pima Indians of Arizona Diabetes. 69. DOI: 10.2337/Db20-532-P |
0.312 |
|
| 2020 |
Rumora AE, Alakwaa F, Andersen ST, Jørgensen ME, Charles M, Callaghan BC, Jensen TS, Feldman EL. 531-P: Metabolomics Identifies Novel Plasma Metabolomic Signatures Associated with Diabetic Neuropathy in a Cohort with Screen-Tested Type 2 Diabetes: ADDITION-Denmark Diabetes. 69. DOI: 10.2337/Db20-531-P |
0.348 |
|
| 2020 |
Eid S, Hinder LM, Hayes JM, Mendelson F, Feldman EL. 529-P: Insulin Replacement Therapy Does Not Fully Prevent Peripheral Neuropathy in Type 1 Diabetic Mice Diabetes. 69. DOI: 10.2337/Db20-529-P |
0.351 |
|
| 2019 |
O'Brien PD, Guo K, Eid SA, Rumora AE, Hinder LM, Hayes JM, Mendelson FE, Hur J, Feldman EL. Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Disease Models & Mechanisms. PMID 31822493 DOI: 10.1242/Dmm.042101 |
0.36 |
|
| 2019 |
Afshinnia F, Nair V, Lin J, Rajendiran TM, Soni T, Byun J, Sharma K, Fort PE, Gardner TW, Looker HC, Nelson RG, Brosius FC, Feldman EL, Michailidis G, Kretzler M, et al. Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians. Jci Insight. PMID 31573977 DOI: 10.1172/Jci.Insight.130317 |
0.332 |
|
| 2019 |
Kim B, Elzinga SE, Henn RE, McGinley LM, Feldman EL. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease. Neurobiology of Disease. 104541. PMID 31349033 DOI: 10.1016/J.Nbd.2019.104541 |
0.321 |
|
| 2019 |
Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. PMID 31346658 DOI: 10.1007/S00125-019-4959-1 |
0.364 |
|
| 2019 |
Rumora AE, Savelieff MG, Sakowski SA, Feldman EL. Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes. International Review of Neurobiology. 145: 127-176. PMID 31208522 DOI: 10.1016/Bs.Irn.2019.05.002 |
0.365 |
|
| 2019 |
Goutman SA, Savelieff MG, Sakowski SA, Feldman EL. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opinion On Investigational Drugs. 1-19. PMID 31189354 DOI: 10.1080/13543784.2019.1627324 |
0.301 |
|
| 2019 |
Elzinga S, Murdock BJ, Guo K, Hayes JM, Tabbey MA, Hur J, Feldman EL. Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Experimental Neurology. 112967. PMID 31145897 DOI: 10.1016/J.Expneurol.2019.112967 |
0.318 |
|
| 2019 |
Guo K, Elzinga S, Eid S, Figueroa-Romero C, Hinder LM, Pacut C, Feldman EL, Hur J. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics. 1-14. PMID 31132961 DOI: 10.1080/15592294.2019.1615352 |
0.346 |
|
| 2019 |
Rumora AE, LoGrasso G, Hayes JM, Mendelson FE, Tabbey MA, Haidar JA, Lentz SI, Feldman EL. The divergent roles of dietary saturated and monounsaturated fatty acids on nerve function in murine models of obesity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30886017 DOI: 10.1523/Jneurosci.3173-18.2019 |
0.359 |
|
| 2019 |
de Anda-Jáuregui G, Guo K, McGregor BA, Feldman EL, Hur J. Correction to: Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone. Bmc Systems Biology. 13: 31. PMID 30866938 DOI: 10.1186/S12918-019-0707-X |
0.322 |
|
| 2019 |
Hinder LM, Sas KM, O'Brien PD, Backus C, Kayampilly P, Hayes JM, Lin CM, Zhang H, Shanmugam S, Rumora AE, Abcouwer SF, Brosius FC, Pennathur S, Feldman EL. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Scientific Reports. 9: 881. PMID 30696927 DOI: 10.1038/S41598-018-37376-Y |
0.378 |
|
| 2019 |
Braffett B, Gubitosi-Klug R, Albers JW, Feldman EL, Martin C, White NH, Orchard TJ, Lopes-Virella MF, Raskin P, Pop-Busui R. 322-OR: Risk Factors for Peripheral and Cardiovascular Autonomic Neuropathy in Type 1 Diabetes: Thirty Years of Follow-Up in DCCT/EDIC Diabetes. 68. DOI: 10.2337/Db19-322-Or |
0.338 |
|
| 2019 |
GUO K, FELDMAN EL, HUR J. 31-LB: Identification of Repurposable Drug Candidate for Diabetic Peripheral Neuropathy Using High-Throughput Drug-Perturbation Data Diabetes. 68: 31-LB. DOI: 10.2337/Db19-31-Lb |
0.322 |
|
| 2018 |
McGregor BA, Eid S, Rumora AE, Murdock B, Guo K, de Anda-Jáuregui G, Porter JE, Feldman EL, Hur J. Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy. Scientific Reports. 8: 17678. PMID 30518872 DOI: 10.1038/S41598-018-36098-5 |
0.359 |
|
| 2018 |
O'Brien PD, Hinder LM, Rumora AE, Hayes JM, Dauch JR, Backus C, Mendelson FE, Feldman EL. Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy. Disease Models & Mechanisms. PMID 30446513 DOI: 10.1242/Dmm.037374 |
0.337 |
|
| 2018 |
Hinder LM, Murdock BJ, Park M, Bender DE, O'Brien PD, Rumora AE, Hur J, Feldman EL. Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story. Experimental Neurology. PMID 29550371 DOI: 10.1016/J.Expneurol.2018.03.011 |
0.382 |
|
| 2018 |
Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, Feldman EL, Callaghan BC, Charles M. Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark. Diabetes Care. PMID 29487078 DOI: 10.2337/Dc17-2062 |
0.337 |
|
| 2018 |
Jaiswal M, Divers J, Pop-Busui R, Feldman EL. Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232. Diabetes Care. 41: e37. PMID 29463674 DOI: 10.2337/Dci17-0058 |
0.355 |
|
| 2018 |
Jaiswal M, Divers J, Urbina EM, Dabelea D, Bell RA, Pettitt DJ, Imperatore G, Pihoker C, Dolan LM, Liese AD, Marcovina S, Linder B, Feldman EL, Pop-Busui R. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study. Pediatric Diabetes. PMID 29292558 DOI: 10.1111/Pedi.12633 |
0.32 |
|
| 2018 |
SAJIC M, KANHAI A, DENTONI G, VARATHARAJAH S, HINDER LM, RUMORA A, FELDMAN EL, SMITH K. High-Fat Diet Induces Mitochondrial Dysfunction in Saphenous Nerve Axons—A Study by Confocal Microscopy In Vivo Diabetes. 67: 60-OR. DOI: 10.2337/Db18-60-Or |
0.318 |
|
| 2018 |
RUMORA A, LOGRASSO G, HAIDAR JA, DOLKOWSKI J, LENTZ SI, FELDMAN EL. Monounsaturated Fatty Acids Prevent Saturated Fatty Acid–Induced Impairment of Mitochondrial Trafficking in Dorsal Root Ganglion Sensory Neurons Diabetes. 67: 573-P. DOI: 10.2337/Db18-573-P |
0.311 |
|
| 2018 |
O'BRIEN PD, GUO K, HINDER LM, HAYES JM, MENDELSON F, TABBEY MA, HUR J, FELDMAN EL. Amelioration of Peripheral Neuropathy in Mouse Models of Diabetes by Dietary Reversal Diabetes. 67: 569-P. DOI: 10.2337/Db18-569-P |
0.32 |
|
| 2018 |
GUO K, ELZINGA S, EID S, FIGUEROA-ROMERO C, MCGREGOR BA, DE ANDA-JÁUREGUI G, PACUT C, FELDMAN EL, HUR J. Large-Scale DNA Methylation Profiling of Human Diabetic Peripheral Neuropathy in Subjects with Type 2 Diabetes Mellitus Diabetes. 67: 551-P. DOI: 10.2337/Db18-551-P |
0.354 |
|
| 2018 |
ELZINGA S, MURDOCK B, HAYES JM, TABBEY MA, FELDMAN EL. Toll-Like Receptors 2/4 and Diabetic Peripheral Neuropathy Diabetes. 67: 32-LB. DOI: 10.2337/Db18-32-Lb |
0.303 |
|
| 2018 |
LOGRASSO G, RUMORA A, HAIDAR JA, LENTZ SI, FELDMAN EL. Saturated Fatty Acids Impair Organellar Trafficking in Dorsal Root Ganglion (DRG) Sensory Neurons Diabetes. 67: 31-LB. DOI: 10.2337/Db18-31-Lb |
0.319 |
|
| 2018 |
EID S, HAYES JM, GUO K, PACUT C, MENDELSON F, HUR J, FELDMAN EL. NOX, NOX, Are You Here? The Emerging Role of NOX5 in Diabetic Neuropathy Diabetes. 67: 30-LB. DOI: 10.2337/Db18-30-Lb |
0.354 |
|
| 2017 |
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, ... Feldman EL, et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care. PMID 28674076 DOI: 10.2337/Dc17-0179 |
0.349 |
|
| 2017 |
Hinder LM, O'Brien PD, Hayes JM, Backus C, Solway AP, Sims-Robinson C, Feldman EL. Dietary reversal of neuropathy in a murine model of prediabetes and the metabolic syndrome. Disease Models & Mechanisms. PMID 28381495 DOI: 10.1242/Dmm.028530 |
0.313 |
|
| 2017 |
Feldman EL, Nave KA, Jensen TS, Bennett DL. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 93: 1296-1313. PMID 28334605 DOI: 10.1016/J.Neuron.2017.02.005 |
0.375 |
|
| 2017 |
O'Brien PD, Hinder LM, Parlee SD, Hayes JM, Backus C, Zhang H, Ma L, Sakowski SA, Brosius FC, Feldman EL. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice. Diabetes, Obesity & Metabolism. PMID 28332276 DOI: 10.1111/Dom.12950 |
0.345 |
|
| 2017 |
Hinder LM, Park M, Rumora AE, Hur J, Eichinger F, Pennathur S, Kretzler M, Brosius FC, Feldman EL. Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease. Journal of Cellular and Molecular Medicine. PMID 28272773 DOI: 10.1111/Jcmm.13136 |
0.382 |
|
| 2017 |
Grisold A, Callaghan BC, Feldman EL. Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 28098594 DOI: 10.1097/Med.0000000000000320 |
0.369 |
|
| 2017 |
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 40: 136-154. PMID 27999003 DOI: 10.2337/Dc16-2042 |
0.371 |
|
| 2017 |
Lovblom LE, Bril V, Orszag A, Edwards K, Pritchard N, Russel A, Pacaud D, Romanchuk K, Mah J, Jeziorska M, Marshall A, Shtein RM, Pop-Busui R, Feldman EL, Boulton AJ. Exploring the optimal diagnostic threshold value of corneal nerve fibre length (CNFL) for diabetic neuropathy (DN) identification Canadian Journal of Diabetes. 41: S62. DOI: 10.1016/J.Jcjd.2017.08.172 |
0.326 |
|
| 2016 |
Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G, Groop PH, Nelson RG, Darshi M, Sharma K, Schelling JR, ... ... Feldman EL, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. Jci Insight. 1: e86976. PMID 27699244 DOI: 10.1172/Jci.Insight.86976 |
0.353 |
|
| 2016 |
Wheelock KM, Jaiswal M, Martin CL, Fufaa GD, Weil EJ, Lemley KV, Yee B, Feldman E, Brosius FC, Knowler WC, Nelson RG, Pop-Busui R. Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. Journal of Diabetes and Its Complications. PMID 27041674 DOI: 10.1016/J.Jdiacomp.2016.03.008 |
0.321 |
|
| 2016 |
Hur J, O'Brien PD, Nair V, Hinder LM, McGregor BA, Jagadish HV, Kretzler M, Brosius FC, Feldman EL. Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns. Diabetologia. PMID 27000313 DOI: 10.1007/S00125-016-3913-8 |
0.361 |
|
| 2016 |
Jaiswal M, Fufaa GD, Martin CL, Pop-Busui R, Nelson RG, Feldman EL. Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes. Diabetes Care. PMID 26908916 DOI: 10.2337/Dc16-0082 |
0.34 |
|
| 2016 |
Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL. Inflammation as a Therapeutic Target for Diabetic Neuropathies. Current Diabetes Reports. 16: 29. PMID 26897744 DOI: 10.1007/S11892-016-0727-5 |
0.364 |
|
| 2016 |
McGinley LM, Sims E, Lunn JS, Kashlan ON, Chen KS, Bruno ES, Pacut CM, Hazel T, Johe K, Sakowski SA, Feldman EL. Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease. Stem Cells Translational Medicine. PMID 26744412 DOI: 10.5966/Sctm.2015-0103 |
0.327 |
|
| 2016 |
Stables CL, Auerbach DS, Whitesall SE, D'Alecy LG, Feldman EL. Differential impact of type-1 and type-2 diabetes on control of heart rate in mice. Autonomic Neuroscience : Basic & Clinical. 194: 17-25. PMID 26725752 DOI: 10.1016/J.Autneu.2015.12.006 |
0.329 |
|
| 2016 |
Perkins BA, Lovblom LE, Bril V, Edwards K, Pritchard N, Russell A, Pacaud D, Romanchuk K, Mah J, Boulton A, Jeziorska M, Marshall A, Shtein RM, Pop-Busui R, Feldman EL, et al. Results of an International Corneal Confocal Microscopy (CCM) Consortium: A Pooled Multicentre Analysis of the Concurrent Diagnostic Validity of CCM to Identify Diabetic Polyneuropathy in Type 1 Diabetes Mellitus Canadian Journal of Diabetes. 40: S20. DOI: 10.1016/J.Jcjd.2016.08.062 |
0.343 |
|
| 2015 |
Chen KS, Sakowski SA, Feldman EL. Intraspinal Stem Cell Transplantation for Amyotrophic Lateral Sclerosis. Annals of Neurology. PMID 26696091 DOI: 10.1002/Ana.24584 |
0.309 |
|
| 2015 |
O'Brien PD, Hur J, Robell NJ, Hayes JM, Sakowski SA, Feldman EL. Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice. Journal of Diabetes and Its Complications. PMID 26525588 DOI: 10.1016/J.Jdiacomp.2015.09.018 |
0.338 |
|
| 2015 |
Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL, Pop-Busui R. Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. Journal of Diabetes and Its Complications. PMID 26264399 DOI: 10.1016/J.Jdiacomp.2015.07.013 |
0.354 |
|
| 2015 |
Kim B, Figueroa-Romero C, Pacut C, Backus C, Feldman EL. Insulin resistance prevents AMPK-induced tau dephosphorylation through Akt-mediated increase in AMPKSer485 phosphorylation. The Journal of Biological Chemistry. PMID 26100639 DOI: 10.1074/Jbc.M115.636852 |
0.317 |
|
| 2015 |
Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC, Feldman EL. The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes. Diabetes. PMID 25979075 DOI: 10.2337/Db15-0133 |
0.367 |
|
| 2015 |
Sims-Robinson C, Bakeman A, Rosko A, Glasser R, Feldman EL. The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain. Molecular Neurobiology. PMID 25976368 DOI: 10.1007/S12035-015-9207-1 |
0.377 |
|
| 2015 |
Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Experimental & Molecular Medicine. 47: e149. PMID 25766618 DOI: 10.1038/Emm.2015.3 |
0.317 |
|
| 2015 |
Lunn JS, Sakowski SA, McGinley LM, Pacut C, Hazel TG, Johe K, Feldman EL. Autocrine production of IGF-I increases stem cell-mediated neuroprotection. Stem Cells (Dayton, Ohio). 33: 1480-9. PMID 25532472 DOI: 10.1002/Stem.1933 |
0.326 |
|
| 2014 |
Hamid HS, Mervak CM, Münch AE, Robell NJ, Hayes JM, Porzio MT, Singleton JR, Smith AG, Feldman EL, Lentz SI. Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves. Annals of Clinical and Translational Neurology. 1: 799-812. PMID 25493271 DOI: 10.1002/Acn3.119 |
0.368 |
|
| 2014 |
O'Brien PD, Hur J, Hayes JM, Backus C, Sakowski SA, Feldman EL. BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses. Neurobiology of Disease. 73: 348-355. PMID 25447227 DOI: 10.1016/J.Nbd.2014.10.015 |
0.371 |
|
| 2014 |
Calabek B, Callaghan B, Feldman EL. Therapy for diabetic neuropathy: an overview. Handbook of Clinical Neurology. 126: 317-33. PMID 25410231 DOI: 10.1016/B978-0-444-53480-4.00022-9 |
0.35 |
|
| 2014 |
Filla LA, Yuan W, Feldman EL, Li S, Edwards JL. Global metabolomic and isobaric tagging capillary liquid chromatography-tandem mass spectrometry approaches for uncovering pathway dysfunction in diabetic mouse aorta. Journal of Proteome Research. 13: 6121-34. PMID 25368974 DOI: 10.1021/Pr501030E |
0.336 |
|
| 2014 |
Callaghan BC, Feldman EL. Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs. Annals of Internal Medicine. 161: 674-5. PMID 25364890 DOI: 10.7326/M14-2157 |
0.323 |
|
| 2014 |
Biessels GJ, Bril V, Calcutt NA, Cameron NE, Cotter MA, Dobrowsky R, Feldman EL, Fernyhough P, Jakobsen J, Malik RA, Mizisin AP, Oates PJ, Obrosova IG, Pop-Busui R, Russell JW, et al. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). Journal of the Peripheral Nervous System : Jpns. 19: 77-87. PMID 24934510 DOI: 10.1111/Jns5.12072 |
0.376 |
|
| 2014 |
O'Brien PD, Sakowski SA, Feldman EL. Mouse models of diabetic neuropathy. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 54: 259-72. PMID 24615439 DOI: 10.1093/Ilar/Ilt052 |
0.377 |
|
| 2014 |
O'Brien PD, Hinder LM, Sakowski SA, Feldman EL. ER stress in diabetic peripheral neuropathy: A new therapeutic target. Antioxidants & Redox Signaling. 21: 621-33. PMID 24382087 DOI: 10.1089/Ars.2013.5807 |
0.372 |
|
| 2014 |
Hinder LM, Figueroa-Romero C, Pacut C, Hong Y, Vivekanandan-Giri A, Pennathur S, Feldman EL. Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. Antioxidants & Redox Signaling. 21: 588-600. PMID 23991914 DOI: 10.1089/Ars.2013.5248 |
0.322 |
|
| 2013 |
Grote CW, Groover AL, Ryals JM, Geiger PC, Feldman EL, Wright DE. Peripheral nervous system insulin resistance in ob/ob mice. Acta Neuropathologica Communications. 1: 15. PMID 24252636 DOI: 10.1186/2051-5960-1-15 |
0.345 |
|
| 2013 |
Jaiswal M, Lauer A, Martin CL, Bell RA, Divers J, Dabelea D, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Rodriguez BL, Pop-Busui R, Feldman EL. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Diabetes Care. 36: 3903-8. PMID 24144652 DOI: 10.2337/Dc13-1213 |
0.346 |
|
| 2013 |
Hur J, Sullivan KA, Callaghan BC, Pop-Busui R, Feldman EL. Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy. Diabetes Care. 36: 4043-9. PMID 24101696 DOI: 10.2337/Dc12-2530 |
0.352 |
|
| 2013 |
Vincent AM, Calabek B, Roberts L, Feldman EL. Biology of diabetic neuropathy. Handbook of Clinical Neurology. 115: 591-606. PMID 23931804 DOI: 10.1016/B978-0-444-52902-2.00034-5 |
0.408 |
|
| 2013 |
Callaghan B, Feldman E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities Annals of Neurology. 74: 397-403. PMID 23929529 DOI: 10.1002/Ana.23986 |
0.319 |
|
| 2013 |
Pop-Busui R, Stevens MJ, Raffel DM, White EA, Mehta M, Plunkett CD, Brown MB, Feldman EL. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia. 56: 1835-44. PMID 23740194 DOI: 10.1007/S00125-013-2942-9 |
0.304 |
|
| 2013 |
Cheng HT, Dauch JR, Porzio MT, Yanik BM, Hsieh W, Smith AG, Singleton JR, Feldman EL. Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. The Journal of Pain : Official Journal of the American Pain Society. 14: 941-7. PMID 23685187 DOI: 10.1016/J.Jpain.2013.03.005 |
0.344 |
|
| 2013 |
Stables CL, Glasser RL, Feldman EL. Diabetic cardiac autonomic neuropathy: insights from animal models. Autonomic Neuroscience : Basic & Clinical. 177: 74-80. PMID 23562143 DOI: 10.1016/J.Autneu.2013.03.001 |
0.358 |
|
| 2013 |
Kim B, Backus C, Oh S, Feldman EL. Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 727-39. PMID 23254634 DOI: 10.3233/Jad-121669 |
0.347 |
|
| 2013 |
Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, Feldman EL. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. The Journal of Endocrinology. 216: 1-11. PMID 23086140 DOI: 10.1530/Joe-12-0356 |
0.371 |
|
| 2013 |
Hinder LM, Vincent AM, Hayes JM, McLean LL, Feldman EL. Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Experimental Neurology. 239: 102-10. PMID 23059459 DOI: 10.1016/J.Expneurol.2012.10.002 |
0.33 |
|
| 2013 |
Hur J, Sullivan K, Pop-Busui R, Callaghan B, Feldman E. HbA1c is associated with sural nerve regeneration and degeneration in diabetic neuropathy Journal of the Neurological Sciences. 333: e697-e698. DOI: 10.1016/J.Jns.2013.07.2410 |
0.355 |
|
| 2012 |
Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG, Dowling JJ, Feldman EL. Neuromuscular effects of G93A-SOD1 expression in zebrafish. Molecular Neurodegeneration. 7: 44. PMID 22938571 DOI: 10.1186/1750-1326-7-44 |
0.312 |
|
| 2012 |
Callaghan BC, Hur J, Feldman EL. Diabetic neuropathy: one disease or two? Current Opinion in Neurology. 25: 536-41. PMID 22892951 DOI: 10.1097/Wco.0B013E328357A797 |
0.358 |
|
| 2012 |
Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. The Cochrane Database of Systematic Reviews. 6: CD007543. PMID 22696371 DOI: 10.1002/14651858.Cd007543.Pub2 |
0.365 |
|
| 2012 |
Sakowski SA, Feldman EL. Insulin-like growth factors in the peripheral nervous system. Endocrinology and Metabolism Clinics of North America. 41: 375-93, vii. PMID 22682636 DOI: 10.1016/J.Ecl.2012.04.020 |
0.313 |
|
| 2012 |
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. The Lancet. Neurology. 11: 521-34. PMID 22608666 DOI: 10.1016/S1474-4422(12)70065-0 |
0.384 |
|
| 2012 |
Sims-Robinson C, Zhao S, Hur J, Feldman EL. Central nervous system endoplasmic reticulum stress in a murine model of Type 2 diabetes Diabetologia. 55: 2276-2284. PMID 22581041 DOI: 10.1007/S00125-012-2573-6 |
0.359 |
|
| 2012 |
Hinder LM, Vincent AM, Burant CF, Pennathur S, Feldman EL. Bioenergetics in diabetic neuropathy: what we need to know. Journal of the Peripheral Nervous System : Jpns. 17: 10-4. PMID 22548617 DOI: 10.1111/J.1529-8027.2012.00389.X |
0.394 |
|
| 2012 |
Oh SS, Sullivan KA, Wilkinson JE, Backus C, Hayes JM, Sakowski SA, Feldman EL. Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems. Neuroscience. 212: 201-13. PMID 22516022 DOI: 10.1016/J.Neuroscience.2012.03.026 |
0.35 |
|
| 2012 |
Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabetic Medicine : a Journal of the British Diabetic Association. 29: 937-44. PMID 22417277 DOI: 10.1111/J.1464-5491.2012.03644.X |
0.355 |
|
| 2012 |
Kim B, Feldman EL. Insulin resistance in the nervous system. Trends in Endocrinology and Metabolism: Tem. 23: 133-41. PMID 22245457 DOI: 10.1016/J.Tem.2011.12.004 |
0.349 |
|
| 2012 |
Cheng HT, Dauch JR, Hayes JM, Yanik BM, Feldman EL. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes. Neurobiology of Disease. 45: 280-7. PMID 21872660 DOI: 10.1016/J.Nbd.2011.08.011 |
0.364 |
|
| 2012 |
Hinder L, Buller C, Pennathur S, Feldman E. Bioenergetic Metabolites in the Diabetic Peripheral Nervous System (IN1-1.007) Neurology. 78: IN1-1.007-IN1-1.007. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In1-1.007 |
0.383 |
|
| 2012 |
Cheng H, Dauch J, Porzio M, Yanik B, Hsieh W, Smith A, Singleton J, Feldman E. Useful Biomarkers for the Diagnosis of Painful Diabetic Neuropathy (IN1-1.004) Neurology. 78: IN1-1.004-IN1-1.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In1-1.004 |
0.315 |
|
| 2012 |
Vincent AM, McLean LL, Pande M, Oh SS, Feldman EL. LOX-1-mediated injury in sensory neurons in type 2 diabetes International Journal of Diabetes and Metabolism. 20: 59-63. DOI: 10.1159/000497727 |
0.37 |
|
| 2011 |
Hur J, Sullivan KA, Pande M, Hong Y, Sima AA, Jagadish HV, Kretzler M, Feldman EL. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain : a Journal of Neurology. 134: 3222-35. PMID 21926103 DOI: 10.1093/Brain/Awr228 |
0.385 |
|
| 2011 |
Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature Reviews. Neurology. 7: 573-83. PMID 21912405 DOI: 10.1038/Nrneurol.2011.137 |
0.401 |
|
| 2011 |
Kim B, McLean LL, Philip SS, Feldman EL. Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology. 152: 3638-47. PMID 21810948 DOI: 10.1210/En.2011-0029 |
0.337 |
|
| 2011 |
Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes/Metabolism Research and Reviews. 27: 620-8. PMID 21695763 DOI: 10.1002/Dmrr.1226 |
0.362 |
|
| 2011 |
Pande M, Hur J, Hong Y, Backus C, Hayes JM, Oh SS, Kretzler M, Feldman EL. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes. 60: 1981-9. PMID 21617178 DOI: 10.2337/Db10-1541 |
0.376 |
|
| 2011 |
Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, Karter AJ. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 34: 635-40. PMID 21285390 DOI: 10.2337/Dc10-0878 |
0.325 |
|
| 2011 |
Kim B, Sullivan KA, Backus C, Feldman EL. Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxidants & Redox Signaling. 14: 1829-39. PMID 21194385 DOI: 10.1089/Ars.2010.3816 |
0.332 |
|
| 2011 |
Schuyler AD, Carlson HA, Feldman EL. Computational methods for identifying a layered allosteric regulatory mechanism for ALS-causing mutations of Cu-Zn superoxide dismutase 1. Proteins. 79: 417-27. PMID 21104697 DOI: 10.1002/Prot.22892 |
0.678 |
|
| 2010 |
Hur J, Sullivan KA, Schuyler AD, Hong Y, Pande M, States DJ, Jagadish HV, Feldman EL. Literature-based discovery of diabetes- and ROS-related targets. Bmc Medical Genomics. 3: 49. PMID 20979611 DOI: 10.1186/1755-8794-3-49 |
0.717 |
|
| 2010 |
Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nature Reviews Neurology. 6: 551-559. PMID 20842183 DOI: 10.1038/Nrneurol.2010.130 |
0.362 |
|
| 2010 |
Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW, Feldman EL, Herman WH. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care. 33: 2635-41. PMID 20833868 DOI: 10.2337/Dc10-0616 |
0.343 |
|
| 2010 |
Oh SS, Hayes JM, Sims-Robinson C, Sullivan KA, Feldman EL. The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice. Neuroscience Letters. 483: 127-31. PMID 20691755 DOI: 10.1016/J.Neulet.2010.07.076 |
0.305 |
|
| 2010 |
Cheng HT, Dauch JR, Oh SS, Hayes JM, Hong Y, Feldman EL. p38 mediates mechanical allodynia in a mouse model of type 2 diabetes. Molecular Pain. 6: 28. PMID 20482876 DOI: 10.1186/1744-8069-6-28 |
0.354 |
|
| 2010 |
Kakoki M, Sullivan KA, Backus C, Hayes JM, Oh SS, Hua K, Gasim AM, Tomita H, Grant R, Nossov SB, Kim HS, Jennette JC, Feldman EL, Smithies O. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 10190-5. PMID 20479236 DOI: 10.1073/Pnas.1005144107 |
0.366 |
|
| 2010 |
Vincent AM, Edwards JL, McLean LL, Hong Y, Cerri F, Lopez I, Quattrini A, Feldman EL. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathologica. 120: 477-89. PMID 20473509 DOI: 10.1007/S00401-010-0697-7 |
0.343 |
|
| 2010 |
Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, Waberski BH, Lachin JM, Albers JW. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Current Diabetes Reports. 10: 276-82. PMID 20464532 DOI: 10.1007/S11892-010-0120-8 |
0.368 |
|
| 2010 |
Lunn JS, Pacut C, Backus C, Hong Y, Johe K, Hefferan M, Marsala M, Feldman EL. The pleotrophic effects of insulin-like growth factor-I on human spinal cord neural progenitor cells. Stem Cells and Development. 19: 1983-93. PMID 20406098 DOI: 10.1089/Scd.2010.0003 |
0.318 |
|
| 2010 |
Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, Waberski BH, Lachin JM. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 33: 1090-6. PMID 20150297 DOI: 10.2337/Dc09-1941 |
0.367 |
|
| 2010 |
Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL. The management of diabetic neuropathy in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 55: 365-85. PMID 20042258 DOI: 10.1053/J.Ajkd.2009.10.050 |
0.314 |
|
| 2010 |
Edwards JL, Quattrini A, Lentz SI, Figueroa-Romero C, Cerri F, Backus C, Hong Y, Feldman EL. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia. 53: 160-9. PMID 19847394 DOI: 10.1007/S00125-009-1553-Y |
0.325 |
|
| 2010 |
Cheng H, Dauch J, Hayes J, Hong Y, Feldman E. P38 mediates mechanical allodynia in a mouse model of type 2 diabetes The Journal of Pain. 11: S25. DOI: 10.1016/J.Jpain.2010.01.107 |
0.331 |
|
| 2009 |
Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. Journal of the Peripheral Nervous System : Jpns. 14: 257-67. PMID 20021567 DOI: 10.1111/J.1529-8027.2009.00237.X |
0.392 |
|
| 2009 |
Kim B, Backus C, Oh S, Hayes JM, Feldman EL. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology. 150: 5294-301. PMID 19819959 DOI: 10.1210/En.2009-0695 |
0.341 |
|
| 2009 |
Cheng HT, Dauch JR, Hayes JM, Hong Y, Feldman EL. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. Journal of Neuropathology and Experimental Neurology. 68: 1229-43. PMID 19816194 DOI: 10.1097/Nen.0B013E3181Bef710 |
0.355 |
|
| 2009 |
Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Developmental Neurobiology. 69: 871-84. PMID 19672955 DOI: 10.1002/Dneu.20747 |
0.309 |
|
| 2009 |
Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes. 58: 2376-85. PMID 19592619 DOI: 10.2337/Db09-0047 |
0.383 |
|
| 2009 |
Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 119: 2886-93. PMID 19470886 DOI: 10.1161/Circulationaha.108.837369 |
0.319 |
|
| 2009 |
Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 58: 1634-40. PMID 19411614 DOI: 10.2337/Db08-1771 |
0.357 |
|
| 2009 |
Schuyler AD, Carlson HA, Feldman EL. Computational methods for predicting sites of functionally important dynamics. The Journal of Physical Chemistry. B. 113: 6613-22. PMID 19378962 DOI: 10.1016/J.Bpj.2008.12.3643 |
0.668 |
|
| 2009 |
Lunn JS, Hefferan MP, Marsala M, Feldman EL. Stem cells: Comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery Growth Factors. 27: 133-140. PMID 19294549 DOI: 10.1080/08977190902814855 |
0.328 |
|
| 2009 |
Hur J, Schuyler AD, States DJ, Feldman EL. SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics (Oxford, England). 25: 838-40. PMID 19188191 DOI: 10.1093/Bioinformatics/Btp049 |
0.673 |
|
| 2009 |
Franz CK, Federici T, Yang J, Backus C, Oh SS, Teng Q, Carlton E, Bishop KM, Gasmi M, Bartus RT, Feldman EL, Boulis NM. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS. Neurobiology of Disease. 33: 473-81. PMID 19135533 DOI: 10.1016/J.Nbd.2008.12.003 |
0.301 |
|
| 2009 |
Vincent AM, Kato K, McLean LL, Soules ME, Feldman EL. Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms Antioxidants and Redox Signaling. 11: 425-438. PMID 19072199 DOI: 10.1089/Ars.2008.2235 |
0.334 |
|
| 2009 |
Sakowski SA, Schuyler AD, Feldman EL. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 63-73. PMID 18608100 DOI: 10.1080/17482960802160370 |
0.71 |
|
| 2009 |
Kern TS, Berkowitz BA, Feldman EL. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary: Advances toward measuring diabetic retinopathy and neuropathy: from the bench to the clinic and back again (April 4-5, 2007, Baltimore, Maryland). Journal of Diabetes and Its Complications. 23: 219-23. PMID 18413183 DOI: 10.1016/J.Jdiacomp.2007.11.001 |
0.36 |
|
| 2008 |
Singleton JR, Bixby B, Russell JW, Feldman EL, Peltier A, Goldstein J, Howard J, Smith AG. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. Journal of the Peripheral Nervous System : Jpns. 13: 218-27. PMID 18844788 DOI: 10.1111/J.1529-8027.2008.00180.X |
0.303 |
|
| 2008 |
Sullivan KA, Kim B, Feldman EL. Minireview: Insulin-like growth factors in the peripheral nervous system Endocrinology. 149: 5963-5971. PMID 18719018 DOI: 10.1210/En.2008-1020 |
0.337 |
|
| 2008 |
Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine & Metabolic Disorders. 9: 301-14. PMID 18709457 DOI: 10.1007/S11154-008-9104-2 |
0.377 |
|
| 2008 |
Zhang H, Saha J, Byun J, Schin M, Lorenz M, Kennedy RT, Kretzler M, Feldman EL, Pennathur S, Brosius FC. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. American Journal of Physiology. Renal Physiology. 295: F1071-81. PMID 18667486 DOI: 10.1152/Ajprenal.90208.2008 |
0.364 |
|
| 2008 |
Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacology & Therapeutics. 120: 1-34. PMID 18616962 DOI: 10.1016/J.Pharmthera.2008.05.005 |
0.377 |
|
| 2008 |
Wiggin TD, Kretzler M, Pennathur S, Sullivan KA, Brosius FC, Feldman EL. Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. Endocrinology. 149: 4928-37. PMID 18583417 DOI: 10.1210/En.2008-0869 |
0.364 |
|
| 2008 |
Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 57: 1439-45. PMID 18511444 DOI: 10.2337/Db08-0061 |
0.375 |
|
| 2008 |
Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiology of Disease. 30: 420-9. PMID 18424057 DOI: 10.1016/J.Nbd.2008.02.013 |
0.372 |
|
| 2008 |
Muller KA, Ryals JM, Feldman EL, Wright DE. Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. Diabetes. 57: 1693-701. PMID 18362211 DOI: 10.2337/Db08-0022 |
0.348 |
|
| 2008 |
Vincent AM, Edwards JL, Sadidi M, Feldman EL. The antioxidant response as a drug target in diabetic neuropathy. Current Drug Targets. 9: 94-100. PMID 18220717 DOI: 10.2174/138945008783431754 |
0.322 |
|
| 2008 |
Sullivan KA, Lentz SI, Roberts JL, Feldman EL. Criteria for creating and assessing mouse models of diabetic neuropathy. Current Drug Targets. 9: 3-13. PMID 18220709 DOI: 10.2174/138945008783431763 |
0.37 |
|
| 2008 |
Vincent AM, Sakowski SA, Schuyler A, Feldman EL. Strategic approaches to developing drug treatments for ALS. Drug Discovery Today. 13: 67-72. PMID 18190866 DOI: 10.1016/J.Drudis.2007.10.011 |
0.697 |
|
| 2008 |
Vincent AM, Feldman EL. Can drug screening lead to candidate therapies for testing in diabetic neuropathy? Antioxidants and Redox Signaling. 10: 387-393. PMID 17961065 DOI: 10.1089/Ars.2007.1815 |
0.329 |
|
| 2008 |
Cheng H, Hayes J, Hong Y, Feldman E. (106) Upregulation of nerve growth factor signaling in painful neuropathy of type 2 diabetes The Journal of Pain. 9: 2. DOI: 10.1016/J.Jpain.2008.01.024 |
0.341 |
|
| 2007 |
Vincent AM, Russell JW, Sullivan KA, Backus C, Hayes JM, McLean LL, Feldman EL. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Experimental Neurology. 208: 216-27. PMID 17927981 DOI: 10.1016/J.Expneurol.2007.07.017 |
0.36 |
|
| 2007 |
Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F, Feldman EL. Mouse models of diabetic neuropathy. Neurobiology of Disease. 28: 276-85. PMID 17804249 DOI: 10.1016/J.Nbd.2007.07.022 |
0.324 |
|
| 2007 |
Cornblath DR, Vinik A, Feldman E, Freeman R, Boulton AJM. Surgical decompression for diabetic sensorimotor polyneuropathy. Diabetes Care. 30: 421-422. PMID 17259523 DOI: 10.2337/Dc06-2324 |
0.37 |
|
| 2007 |
Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, Feldman EL. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology. 148: 548-58. PMID 17095586 DOI: 10.1210/En.2006-0073 |
0.357 |
|
| 2006 |
Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nature Clinical Practice. Neurology. 2: 620-8. PMID 17057749 DOI: 10.1038/Ncpneuro0320 |
0.686 |
|
| 2006 |
Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR. Lifestyle intervention for pre-diabetic neuropathy Diabetes Care. 29: 1294-1299. PMID 16732011 DOI: 10.2337/Dc06-0224 |
0.342 |
|
| 2006 |
Leinninger GM, Backus C, Sastry AM, Yi YB, Wang CW, Feldman EL. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiology of Disease. 23: 11-22. PMID 16684605 DOI: 10.1016/J.Nbd.2006.01.017 |
0.67 |
|
| 2006 |
Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 29: 340-4. PMID 16443884 DOI: 10.2337/Diacare.29.02.06.Dc05-1549 |
0.329 |
|
| 2005 |
Vincent AM, Stevens MJ, Backus C, McLean LL, Feldman EL. Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxidants & Redox Signaling. 7: 1494-506. PMID 16356113 DOI: 10.1089/Ars.2005.7.1494 |
0.335 |
|
| 2005 |
Sullivan KA, Feldman EL. New developments in diabetic neuropathy Current Opinion in Neurology. 18: 586-590. PMID 16155445 DOI: 10.1097/01.Wco.0000178825.56414.52 |
0.399 |
|
| 2005 |
Schwab TS, Madison BB, Grauman AR, Feldman EL. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells. Apoptosis : An International Journal On Programmed Cell Death. 10: 831-40. PMID 16133873 DOI: 10.1007/S10495-005-0429-Y |
0.3 |
|
| 2005 |
Russo VC, Gluckman PD, Feldman EL, Werther GA. The insulin-like growth factor system and its pleiotropic functions in brain Endocrine Reviews. 26: 916-943. PMID 16131630 DOI: 10.1210/Er.2004-0024 |
0.318 |
|
| 2005 |
Vincent AM, Backus C, Taubman AA, Feldman EL. Identification of candidate drugs for the treatment of ALS Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 6: 29-36. PMID 16036423 DOI: 10.1080/14660820510026171 |
0.303 |
|
| 2005 |
Leinninger GM, Feldman EL. Insulin-like growth factors in the treatment of neurological disease. Endocrine Development. 9: 135-59. PMID 15879695 DOI: 10.1159/000085763 |
0.673 |
|
| 2005 |
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 28: 956-62. PMID 15793206 DOI: 10.2337/Diacare.28.4.956 |
0.378 |
|
| 2005 |
Meyer G, Kim B, Van Golen C, Feldman EL. Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility Cellular and Molecular Life Sciences. 62: 461-470. PMID 15719172 DOI: 10.1007/S00018-004-4456-6 |
0.56 |
|
| 2005 |
Vincent AM, McLean LL, Backus C, Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons Faseb Journal. 19: 638-640. PMID 15677696 DOI: 10.1096/Fj.04-2513Fje |
0.345 |
|
| 2005 |
Meyer A, van Golen CM, Boyanapalli M, Kim B, Soules ME, Feldman EL. Integrin-linked kinase complexes with caveolin-1 in human neuroblastoma cells. Biochemistry. 44: 932-8. PMID 15654749 DOI: 10.1021/Bi048619R |
0.552 |
|
| 2005 |
Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with impaired glucose tolerance: Implication for diagnosis and therapy Current Treatment Options in Neurology. 7: 33-42. DOI: 10.1007/S11940-005-0004-4 |
0.312 |
|
| 2004 |
Vincent AM, Feldman EL, Song DK, Jung V, Schild A, Zhang W, Imperiale MJ, Boulis NM. Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro. Neuromolecular Medicine. 6: 79-85. PMID 15970625 DOI: 10.1385/Nmm:6:2-3:079 |
0.33 |
|
| 2004 |
Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1544-6. PMID 15319368 DOI: 10.1096/Fj.04-1581Fje |
0.667 |
|
| 2004 |
Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews. 25: 612-28. PMID 15294884 DOI: 10.1210/Er.2003-0019 |
0.35 |
|
| 2004 |
Meyer A, van Golen CM, Kim B, van Golen KL, Feldman EL. Integrin expression regulates neuroblastoma attachment and migration. Neoplasia (New York, N.Y.). 6: 332-42. PMID 15256055 DOI: 10.1593/Neo.03445 |
0.558 |
|
| 2004 |
Vincent AM, Feldman EL. New insights into the mechanisms of diabetic neuropathy Reviews in Endocrine and Metabolic Disorders. 5: 227-236. PMID 15211094 DOI: 10.1023/B:Remd.0000032411.11422.E0 |
0.35 |
|
| 2004 |
Vincent AM, Mobley BC, Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death Neurobiology of Disease. 16: 407-416. PMID 15193297 DOI: 10.1016/J.Nbd.2004.03.001 |
0.321 |
|
| 2004 |
Layton BE, Sastry AM, Wang H, Sullivan KA, Feldman EL, Komorowski TE, Philbert MA. Differences between collagen morphologies, properties and distribution in diabetic and normal biobreeding and Sprague-Dawley rat sciatic nerves. Journal of Biomechanics. 37: 879-88. PMID 15111075 DOI: 10.1016/J.Jbiomech.2003.11.008 |
0.358 |
|
| 2004 |
Leinninger GM, Russell JW, van Golen CM, Berent A, Feldman EL. Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death and Differentiation. 11: 885-96. PMID 15105834 DOI: 10.1038/Sj.Cdd.4401429 |
0.653 |
|
| 2004 |
Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. Journal of the Peripheral Nervous System : Jpns. 9: 26-53. PMID 14871451 DOI: 10.1111/J.1085-9489.2004.09105.X |
0.691 |
|
| 2003 |
Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 52: 2867-73. PMID 14633845 DOI: 10.2337/Diabetes.52.12.2867 |
0.334 |
|
| 2003 |
Feldman EL. Oxidative stress and diabetic neuropathy: A new understanding of an old problem Journal of Clinical Investigation. 111: 431-433. PMID 12588877 DOI: 10.1172/Jci17862 |
0.367 |
|
| 2002 |
Meyer G, Feldman EL. Signaling mechanisms that regulate actin-based motility processes in the nervous system Journal of Neurochemistry. 83: 490-503. PMID 12390511 DOI: 10.1046/J.1471-4159.2002.01185.X |
0.543 |
|
| 2002 |
Simmons Z, Feldman EL. Update on diabetic neuropathy Current Opinion in Neurology. 15: 595-603. PMID 12352003 DOI: 10.1097/00019052-200210000-00010 |
0.395 |
|
| 2002 |
Kim B, Feldman EL. Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and Akt Journal of Biological Chemistry. 277: 27393-27400. PMID 12011046 DOI: 10.1074/Jbc.M201963200 |
0.307 |
|
| 2001 |
Meyer GE, Shelden E, Kim B, Feldman EL. Insulin-like growth factor I stimulates motility in human neuroblastoma cells. Oncogene. 20: 7542-50. PMID 11709726 DOI: 10.1038/Sj.Onc.1204927 |
0.572 |
|
| 2001 |
Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH, Dyck PJ, Dyck PJ, Feldman EL, Fields HL, Grant IA, Griffin JW, Klein CJ, Lindblom U, Litchy WJ, et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. Journal of the Neurological Sciences. 189: 3-5. PMID 11596565 DOI: 10.1016/S0022-510X(01)00584-6 |
0.317 |
|
| 2001 |
Robinson Singleton J, Feldman EL. Insulin-like growth factor-I in muscle metabolism and myotherapies Neurobiology of Disease. 8: 541-554. PMID 11493020 DOI: 10.1006/Nbdi.2001.0416 |
0.311 |
|
| 2001 |
Delaney CL, Russell JW, Cheng HL, Feldman EL. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. Journal of Neuropathology and Experimental Neurology. 60: 147-60. PMID 11273003 DOI: 10.1093/Jnen/60.2.147 |
0.375 |
|
| 2001 |
Cheng HL, Steinway ML, Xin X, Feldman EL. Insulin-like growth factor-I and Bcl-XL inhibit c-jun N-terminal kinase activation and rescue Schwann cells from apoptosis Journal of Neurochemistry. 76: 935-943. PMID 11158266 DOI: 10.1046/J.1471-4159.2001.00110.X |
0.302 |
|
| 2000 |
Van Golen CM, Feldman EL. Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis Journal of Cellular Physiology. 182: 24-32. PMID 10567913 DOI: 10.1002/(Sici)1097-4652(200001)182:1<24::Aid-Jcp3>3.0.Co;2-6 |
0.305 |
|
| 2000 |
Delaney CL, Feldman EL. Review ■ : Insulin-like Growth Factor-I and Apoptosis in Glial Cell Biology The Neuroscientist. 6: 39-47. DOI: 10.1177/107385840000600112 |
0.332 |
|
| 2000 |
Pop‐Busui R, Sullivan K, Russel J, Feldman E, Stockert C, Larkin D, Greene D, Stevens M. Taurine Replacement Prevents Apoptosis In Experimental Diabetic Neuropathy Journal of the Peripheral Nervous System. 5: 179-180. DOI: 10.1046/J.1529-8027.2000Abstracts-37.X |
0.338 |
|
| 1999 |
Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Current Opinion in Neurology. 12: 553-63. PMID 10590892 DOI: 10.1097/00019052-199910000-00009 |
0.347 |
|
| 1999 |
Delaney CL, Cheng HL, Feldman EL. Insulin-like growth factor-I prevents caspasemediated apoptosis in Schwann cells Journal of Neurobiology. 41: 540-548. PMID 10590177 DOI: 10.1002/(Sici)1097-4695(199912)41:4<540::Aid-Neu9>3.0.Co;2-P |
0.316 |
|
| 1999 |
Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiology of Disease. 6: 347-63. PMID 10527803 DOI: 10.1006/Nbdi.1999.0254 |
0.384 |
|
| 1999 |
Cheng HL, Shy M, Feldman EL. Regulation of insulin-like growth factor-binding protein-5 expression during schwann cell differentiation Endocrinology. 140: 4478-4485. PMID 10499501 DOI: 10.1210/Endo.140.10.7051 |
0.301 |
|
| 1999 |
Greene DA, Stevens MJ, Feldman EL. Diabetic neuropathy: Scope of the syndrome American Journal of Medicine. 107. PMID 10484039 DOI: 10.1016/S0002-9343(99)00007-8 |
0.395 |
|
| 1999 |
Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy European Journal of Pharmacology. 375: 217-223. PMID 10443578 DOI: 10.1016/S0014-2999(99)00356-8 |
0.386 |
|
| 1999 |
Anlar B, Sullivan KA, Feldman EL. Insulin-like growth factor-I and central nervous system development Hormone and Metabolic Research. 31: 120-125. PMID 10226791 DOI: 10.1055/S-2007-978708 |
0.323 |
|
| 1999 |
Russell JW, Feldman EL. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 31: 90-6. PMID 10226787 DOI: 10.1055/S-2007-978704 |
0.377 |
|
| 1999 |
Hogikyan RV, Wald JJ, Feldman EL, Greene DA, Halter JB, Supiano MA. Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes. Metabolism: Clinical and Experimental. 48: 495-500. PMID 10206444 DOI: 10.1016/S0026-0495(99)90110-5 |
0.341 |
|
| 1998 |
Russell JW, Windebank AJ, Schenone A, Feldman EL. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. Journal of Neurobiology. 36: 455-67. PMID 9740019 DOI: 10.1002/(Sici)1097-4695(19980915)36:4<455::Aid-Neu1>3.0.Co;2-V |
0.332 |
|
| 1998 |
Stevens MJ, Dayanikli F, Raffel DM, Allman KC, Sandford T, Feldman EL, Wieland DM, Corbett J, Schwaiger M. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. Journal of the American College of Cardiology. 31: 1575-84. PMID 9626837 DOI: 10.1016/S0735-1097(98)00128-4 |
0.301 |
|
| 1997 |
Feldman EL, Sullivan KA, Kim B, Russell JW. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiology of Disease. 4: 201-14. PMID 9361296 DOI: 10.1006/Nbdi.1997.0156 |
0.311 |
|
| 1997 |
Matthews CC, Odeh HM, Feldman EL. Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience. 79: 525-34. PMID 9200735 DOI: 10.1016/S0306-4522(96)00611-2 |
0.325 |
|
| 1997 |
Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusanio F. A multicenter study on the prevalence of diabetic neuropathy in Italy Diabetes Care. 20: 836-843. PMID 9135952 DOI: 10.2337/Diacare.20.5.836 |
0.361 |
|
| 1997 |
Cheng HL, Feldman EL. Insulin-like growth Factor-I (IGF-I) and IGF binding protein-5 in Schwann cell differentiation Journal of Cellular Physiology. 171: 161-167. PMID 9130463 DOI: 10.1002/(Sici)1097-4652(199705)171:2<161::Aid-Jcp6>3.0.Co;2-M |
0.311 |
|
| 1997 |
Sullivan KA, Bhumsoo K, Buzdon M, Feldman EL. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells Brain Research. 744: 199-206. PMID 9027379 DOI: 10.1016/S0006-8993(96)01078-5 |
0.301 |
|
| 1997 |
Leventhal PS, Feldman EL. Insulin-like growth factors as regulators of cell motility: Signaling mechanisms Trends in Endocrinology and Metabolism. 8: 1-6. DOI: 10.1016/S1043-2760(96)00202-0 |
0.308 |
|
| 1997 |
Greene DA, Stevens MJ, Feldman EL, Thomas TP. The DCCT, metabolism and diabetic neuropathy: Perspectives for the fourth international symposium on diabetic neuropathy Neuroscience Research Communications. 21: 1-4. DOI: 10.1002/(Sici)1520-6769(199707)21:1<1::Aid-Nrc201>3.0.Co;2-L |
0.348 |
|
| 1996 |
Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins Journal of Biological Chemistry. 271: 31791-31794. PMID 8943217 DOI: 10.1074/Jbc.271.50.31791 |
0.307 |
|
| 1996 |
Cheng HL, Sullivan KA, Feldman EL. Immunohistochemical localization of insulin-like growth factor binding protein-5 in the developing rat nervous system Developmental Brain Research. 92: 211-218. PMID 8738128 DOI: 10.1016/0165-3806(96)00016-8 |
0.324 |
|
| 1996 |
Stevens MJ, Lattimer SA, Feldman EL, Helton ED, Millington DS, Sima AA, Greene DA. Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. Metabolism: Clinical and Experimental. 45: 865-72. PMID 8692023 DOI: 10.1016/S0026-0495(96)90161-4 |
0.353 |
|
| 1996 |
Cheng HL, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. Journal of Neurochemistry. 66: 525-36. PMID 8592122 DOI: 10.1046/J.1471-4159.1996.66020525.X |
0.313 |
|
| 1996 |
Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. Journal of Cellular Physiology. 166: 323-31. PMID 8591992 DOI: 10.1002/(Sici)1097-4652(199602)166:2<323::Aid-Jcp10>3.0.Co;2-C |
0.312 |
|
| 1995 |
Stevens MJ, Feldman EL, Greene DA. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects Diabetic Medicine. 12: 566-579. PMID 7554777 DOI: 10.1111/J.1464-5491.1995.Tb00544.X |
0.339 |
|
| 1994 |
Stevens MJ, Dananberg J, Feldman EL, Lattimer SA, Kamijo M, Thomas TP, Shindo H, Sima AA, Greene DA. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. The Journal of Clinical Investigation. 94: 853-9. PMID 8040341 DOI: 10.1172/Jci117406 |
0.327 |
|
| 1994 |
Feldman EL, Stevens MJ. Clinical Testing in Diabetic Peripheral Neuropathy Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 21: S3-S7. PMID 7874610 DOI: 10.1017/S0317167100040671 |
0.362 |
|
| 1994 |
Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 17: 1281-9. PMID 7821168 DOI: 10.2337/Diacare.17.11.1281 |
0.343 |
|
| 1993 |
Sumantran VN, Feldman EL. Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells Endocrinology. 132: 2017-2023. PMID 8477653 DOI: 10.1210/Endo.132.5.8477653 |
0.313 |
|
| 1993 |
Simmons Z, Bromberg MB, Feldman EL, Blaivas M. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Muscle & Nerve. 16: 77-83. PMID 8380902 DOI: 10.1002/Mus.880160113 |
0.31 |
|
| 1993 |
Greene DA, Sima AA, Stevens MJ, Feldman EL, Killen PD, Henry DN, Thomas T, Dananberg J, Lattimer SA. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Diabetes/Metabolism Reviews. 9: 189-217. PMID 8187607 DOI: 10.1002/Dmr.5610090304 |
0.34 |
|
| 1992 |
Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 15: 1902-25. PMID 1464245 DOI: 10.2337/Diacare.15.12.1902 |
0.373 |
|
| 1992 |
Martin DM, Yee D, Carlson RO, Feldman EL. Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines Molecular Brain Research. 15: 241-246. PMID 1331680 DOI: 10.1016/0169-328X(92)90114-Q |
0.306 |
|
| 1992 |
Greene D, Nakamura J, Thomas T, Lattimer-Greene S, Henry D, Feldman E, Stevens M, Killen P, Sima A. The myo-inositol (MI) depletion hypothesis of diabetic complications Experimental Eye Research. 55: 166. DOI: 10.1016/0014-4835(92)90778-Q |
0.335 |
|
| 1990 |
Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome Annals of Neurology. 27: 304-315. PMID 2327738 DOI: 10.1002/Ana.410270313 |
0.302 |
|
| Show low-probability matches. |